292 related articles for article (PubMed ID: 32193748)
1. Multi-functionalized nanocarriers targeting bacterial reservoirs to overcome challenges of multi drug-resistance.
Kiani MH; Imran M; Raza A; Shahnaz G
Daru; 2020 Jun; 28(1):319-332. PubMed ID: 32193748
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of aptamer targeted teicoplanin encapsulated PLGA nanoparticles for Staphylococcus aureus strains.
Ucak S; Sudagidan M; Borsa BA; Mansuroglu B; Ozalp VC
World J Microbiol Biotechnol; 2020 Apr; 36(5):69. PubMed ID: 32333113
[TBL] [Abstract][Full Text] [Related]
3. Use of nanoparticles as therapy for methicillin-resistant Staphylococcus aureus infections.
Liu PF; Lo CW; Chen CH; Hsieh MF; Huang CM
Curr Drug Metab; 2009 Oct; 10(8):875-84. PubMed ID: 20214581
[TBL] [Abstract][Full Text] [Related]
4. The role of nanotechnology in combating multi-drug resistant bacteria.
Singh R; Smitha MS; Singh SP
J Nanosci Nanotechnol; 2014 Jul; 14(7):4745-56. PubMed ID: 24757944
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology as a therapeutic tool to combat microbial resistance.
Pelgrift RY; Friedman AJ
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
[TBL] [Abstract][Full Text] [Related]
6. Role of Nanocarrier Systems in Drug Delivery for Overcoming Multi-Drug Resistance in Bacteria.
Qumsani AT
Pak J Biol Sci; 2023 Feb; 26(3):131-137. PubMed ID: 37480270
[TBL] [Abstract][Full Text] [Related]
7. A novel antibiotic-delivery system by using ovotransferrin as targeting molecule.
Ibrahim HR; Tatsumoto S; Ono H; Van Immerseel F; Raspoet R; Miyata T
Eur J Pharm Sci; 2015 Jan; 66():59-69. PubMed ID: 25315410
[TBL] [Abstract][Full Text] [Related]
8. Nano-therapeutics: A revolution in infection control in post antibiotic era.
Zaidi S; Misba L; Khan AU
Nanomedicine; 2017 Oct; 13(7):2281-2301. PubMed ID: 28673854
[TBL] [Abstract][Full Text] [Related]
9. Nanostructured Therapeutic Carriers for Tuberculosis Treatment: Approaches & Challenges.
Ullah Z; Athar MT; Samad A
Recent Pat Antiinfect Drug Discov; 2017; 12(2):128-137. PubMed ID: 28990537
[TBL] [Abstract][Full Text] [Related]
10. Loxapine, an antipsychotic drug, suppresses intracellular multiple-antibiotic-resistant Salmonella enterica serovar Typhimurium in macrophages.
Yang CY; Hsu CY; Fang CS; Shiau CW; Chen CS; Chiu HC
J Microbiol Immunol Infect; 2019 Aug; 52(4):638-647. PubMed ID: 31239204
[TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. New strategies for combating multidrug-resistant bacteria.
Wright GD; Sutherland AD
Trends Mol Med; 2007 Jun; 13(6):260-7. PubMed ID: 17493872
[TBL] [Abstract][Full Text] [Related]
13. Folic acid-modified mesoporous silica nanoparticles with pH-responsiveness loaded with Amp for an enhanced effect against anti-drug-resistant bacteria by overcoming efflux pump systems.
Chen X; Liu Y; Lin A; Huang N; Long L; Gang Y; Liu J
Biomater Sci; 2018 Jun; 6(7):1923-1935. PubMed ID: 29850668
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
15. Photoexcited quantum dots for killing multidrug-resistant bacteria.
Courtney CM; Goodman SM; McDaniel JA; Madinger NE; Chatterjee A; Nagpal P
Nat Mater; 2016 May; 15(5):529-34. PubMed ID: 26779882
[TBL] [Abstract][Full Text] [Related]
16. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
Penchovsky R; Traykovska M
Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
[TBL] [Abstract][Full Text] [Related]
17. Targeting Intracellular Bacteria with Dual Drug-loaded Lactoferrin Nanoparticles.
Andima M; Boese A; Paul P; Koch M; Loretz B; Lehr CM
ACS Infect Dis; 2024 May; 10(5):1696-1710. PubMed ID: 38577780
[TBL] [Abstract][Full Text] [Related]
18. Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB)--a novel, patentable approach to limit the emergence of XDR-TB.
Martins M
Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):110-7. PubMed ID: 21517742
[TBL] [Abstract][Full Text] [Related]
19. Kill the Real with the Fake: Eliminate Intracellular Staphylococcus aureus Using Nanoparticle Coated with Its Extracellular Vesicle Membrane as Active-Targeting Drug Carrier.
Gao F; Xu L; Yang B; Fan F; Yang L
ACS Infect Dis; 2019 Feb; 5(2):218-227. PubMed ID: 30489062
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
